Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2286c1f7e44a3ae

Jump to content

Roledumab

Add links
From Wikipedia, the free encyclopedia
Roledumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetRHD
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 X markNcheckY (what is this?)  (verify)

Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1][2]

It is currently at Phase III trials for Rh disease.

References

[edit]
  1. ↑ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
  2. ↑ Kaplon H, Reichert JM (2018). "Antibodies to watch in 2018". mAbs. 10 (2): 183–203. doi:10.1080/19420862.2018.1415671. PMC 5825203. PMID 29300693.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Roledumab&oldid=1154587963"